OHI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Omega Healthcare Investors Inc (OHI) is not a strong buy at this time for a beginner investor with a long-term strategy. Despite solid financial growth in the latest quarter, the recent analyst downgrades, regulatory risks, and reduced acquisition volume assumptions indicate challenges ahead. The technical indicators are moderately positive, but the lack of strong trading signals and mixed sentiment from options and news suggest holding off on investment for now.
The MACD is positive and expanding, indicating bullish momentum. The RSI is in the neutral zone at 74.447, and the moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its first resistance level (R1: 46.65), with support at S1: 44.618. However, the pre-market price of 46.5 shows a slight decline of -0.17%, suggesting caution.
Hedge funds are increasing their positions in OHI, with a 251.64% increase in buying over the last quarter. The company's financials for Q4 2025 show strong YoY growth in revenue (14.28%), net income (44.53%), and EPS (34.15%).
BofA downgraded the stock to Underperform, citing heightened competition, regulatory risks, and asset quality concerns. Analysts have reduced FY26 AFFO estimates and acquisition volume assumptions, reflecting a challenging outlook. Regulatory risks in the skilled nursing facility (SNF) subsector could pressure tenant coverage and valuation.
In Q4 2025, revenue increased to $319.2M (up 14.28% YoY), net income rose to $163.8M (up 44.53% YoY), and EPS improved to $0.55 (up 34.15% YoY). However, gross margin slightly declined to 98.63% (-0.14% YoY).
Recent analyst ratings are mixed to negative. BofA downgraded the stock to Underperform with a price target of $46, citing regulatory and competitive pressures. Wells Fargo and Truist raised price targets to $47 and $48, respectively, but maintained neutral or hold ratings. Cantor Fitzgerald and UBS are more optimistic, with price targets of $52, but these are overshadowed by recent downgrades.
